Back to search results

Improving Screening Mammography for Black Women

This study aims to improve screening mammography rates among Black women. It is testing different ways to remind and support women in getting their mammograms. These include an appointment mail reminder, telephone counseling to help overcome barriers, a digital video explaining the mammogram procedure sent by text, and an automated phone call reminder. We want to see if these methods can reduce the number of missed appointments (no-show rate). You may be able to join if you are a Black woman, at least 40 years old, speak English, and have a screening mammogram scheduled within 8 weeks. The study is currently unclear on its recruitment status and plans to enroll 176 participants.

Study design
This is a randomized clinical trial, meaning participants will be assigned by chance to receive one of the different reminder or support methods. The study plans to enroll 176 women.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will measure the no-show rate for appointments 6 months after you join.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07549139

Overcoming Racial Disparities in Screening Mammography

Not Yet Recruiting
NAAges 40+InterventionalHealth services
Washington University School of Medicine
~176 participants
Updated 2026-08-12 on ClinicalTrials.gov
What's tested:Appointment mail reminderTelephone counselingDigital navigation videoAutomated phone call

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
No-show rate
Measured over 6 months after randomization

Conditions

Breast Cancer
Cancer of the Breast

Explore related trials

Breast Carcinoma

Where it's being run

1 sites across 1 states
Missouri1

Study leadership

  • Foluso Ademuyiwa, MD, MPH, MSCI · PRINCIPAL_INVESTIGATOR · Washington University School of Medicine

Who to contact

Foluso Ademuyiwa, MD, MPH, MSCI
[email protected]
314-362-5654
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Woman
At least 40 years old
Self-identify as Black
English-speaking
Scheduled for a screening mammogram within 8 weeks of study entry
Able to understand and willing to sign an IRB approved written informed consent document.

Exclusion

A previous history of breast cancer
Scheduled for a diagnostic mammogram
Has a documented or uncorrectable cognitive, hearing, or visual impairment.
Too ill to participate (diagnosed with or suffering from a condition that, in the judgment of the investigator, may limit participation in the study).

What this trial measures

  • No-show rate6 months after randomization

    Defined as the proportion of participants who do not complete (or do not reschedule) their screening mammogram appointment within 6 months of randomization.